Study record

Novel Insights into Mitochondrial DNA: Mitochondrial Microproteins and mtDNA Variants Modulate Athletic Performance and Age-Related Diseases

Kumagai H, Miller B, Kim SJ et al. · Genes (Basel) · 2023

ReviewSeveralEvidence tier R

What this study reported

Reviewed sports genetics research and mitochondrial microproteins, listing MOTS-c among ten identified mitochondrial-derived peptides alongside humanin, SHLPs 1-6, SHMOOSE and Gau. Summarised reported roles for these microproteins in regulating mitochondrial function and their proposed relevance to athletic performance and age-related disease.

Limitations

Narrative review with no stated search strategy or quality appraisal; MOTS-c is covered as one of many microproteins and polymorphisms, so its specific evidence base is not separately assessed.

Study record

Annotated fields for this study
Study modelReview
Substance studiedSeveralMore than one of these is central to the paper (common for reviews).
SpeciesNot reported
System studiedPublished literature on sports genetics, mitochondrial DNA variants and mitochondrial microproteins
PopulationNot reported
DesignNarrative review
Sample size as reportedNot reported
Control groupNot reported
Route (data field only)Not reported
Endpoints measuredgenetic polymorphisms and athletic performance; sports injury genetic markers; mitochondrial microprotein biology; age-related disease associations
Pathways measuredNot reported
Research areasExercise · Aging · Mitochondrial biology
Evidence tierR — Review (context, not evidence)
Publication typesJournal Article, Review, Research Support, N.I.H., Extramural

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Peripheral
Model applicability
n/a
Sample size
n/a
Controls
n/a
Outcome validity
n/a
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.